ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Historical Holders from Q4 2021 to Q3 2025

CUSIP: 29664WAB1
Type / Class: Debt / NOTE 4.000%11/1
All holders as of September 30, 2025: Q3 2025
Total 13F principal, excl. options: 28.7M
Holdings value: $41M
% of all portfolios: 0%
Grand Portfolio weight change: 0%
Number of holders: 9
Number of buys: 3
Number of sells: -2
Average Value change %: 0%
Average buys %: +0%
Average sells %: -0.001%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Period	Principal	Value	Change	Price	Investors
2025 Q3	$28.7M	$41M	-$315K	$1.00	9
2025 Q2	$21.4M	$40.7M	+$259K	$0.99	11
2025 Q1	$17.8M	$37.2M	+$4.76M	$0.98	9
2024 Q4	$33.2M	$32.2M	-$171M	$0.97	6
2024 Q3	$206M	$256M	-$4.68M	$0.95	16
2024 Q2	$152M	$188M	+$195K	$0.92	18
2024 Q1	$168M	$172M	-$14.9B	$0.83	17
2023 Q4	$210M	$123M	+$10.8M	$0.58	18
2023 Q3	$192M	$111M	-$4.4M	$0.52	17
2023 Q2	$198M	$109M	-$6.11M	$0.50	18
2023 Q1	$237M	$104M	-$397K	$0.40	20
2022 Q4	$235M	$133M	+$4.39M	$0.55	20
2022 Q3	$215M	$128M	-$42.8K	$0.56	19
2022 Q2	$215M	$126M	+$772K	$0.54	19
2022 Q1	$212M	$119M	+$5.21M	$0.52	20
2021 Q4	$200M	$116M	+$116M	$0.53	17